Abstract

BackgroundWritten medicine information can play an important role in educating consumers about their medicines. In Australia, standardised, comprehensive written information known as Consumer Medicine Information (CMI) is available for all prescription medicines. CMI is reportedly under-utilised by general practitioners (GPs) and community pharmacists in consultations, despite consumer desire for medicine information. This study aimed to determine consumers’, GPs’ and community pharmacists’ preferences for CMI provision and identify barriers and facilitators to its use.MethodStructured questionnaires were developed and administered to a national sample of Australian consumers (phone survey), community pharmacists and GPs (postal surveys) surrounding utilisation of CMI. Descriptive and comparative analyses were conducted.ResultsHalf of consumers surveyed wanted to receive CMI for their prescription medicine, with spoken information preferable to written medicine information for many consumers and healthcare professionals. GPs and pharmacists remained a preferred source of medicine information for consumers, although package inserts were appealing to many among all three cohorts. Overall pharmacists were the preferred provider of CMI primarily due to their medicine expertise, accessibility and perceived availability. GPs preferred CMI dissemination through both the GP and pharmacist. Some consumers preferred GPs as the provider of medicines information because of their knowledge of the patients’ medicines and/or medical history, regularity of seeing the patient and good relationship with the patient. Common barriers to CMI provision cited included: time constraints, CMI length and perceptions that patients are not interested in receiving CMI. Facilitators to enhance provision included: strategies to increase consumer awareness, longer consultation times and counseling appointments, and improvements to pharmacy software technology and workflow.ConclusionMedicine information is important to consumers, whether as spoken, written or a combination of both. A tailored approach is needed to ascertain individual patient preference for delivery and scope of medicine information desired so that appropriate information is provided. The barriers of time and perceived attitudes of healthcare practitioners present challenges which may be overcome through changes to workplace practices, adoption of identified facilitators, and education about the positive benefits of CMI as a tool to engage and empower patients.

Highlights

  • Introduction to survey samplingBeverly Hills: Sage Publications; 1983.23

  • The barriers of time and perceived attitudes of healthcare practitioners present challenges which may be overcome through changes to workplace practices, adoption of identified facilitators, and education about the positive benefits of Consumer Medicine Information (CMI) as a tool to engage and empower patients

  • Fifty-four percent (n = 189) of pharmacists were female with a median age of 47 years, whilst 52% (n = 93) of general practitioners (GPs) were female with a median age of 52 years

Read more

Summary

Introduction

Introduction to survey samplingBeverly Hills: Sage Publications; 1983.23. Newnham GM, Burns WI, Snyder RD, Dowling AJ, Ranieri NF, Gray EL, McLachlan SA: Attitudes of oncology health professionals to information from the Internet and other media. In Australia, standardised, comprehensive written information known as Consumer Medicine Information (CMI) is available for all prescription medicines. CMI is reportedly under-utilised by general practitioners (GPs) and community pharmacists in consultations, despite consumer desire for medicine information. Written medicine information in the form of standardized Consumer Medicine Information (CMI) has been a topic of interest and debate since its introduction in Australia in 1993. CMI are standardised, brand-specific written information for consumers about prescription and pharmacistonly medicines prepared by pharmaceutical manufacturers [13]. CMI must be available to consumers either as a package insert or in a format enabling the information to be provided to the end-user of the medicine, for example electronically through healthcare professional dispensing or prescribing software, or via the Internet on Government and third-party websites [13]. Doctors and pharmacists have a duty of care to provide medicine information, whether spoken and/or written, and as such guidelines have been produced to assist them in their legal and professional obligations [15,16,17]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call